Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case

  • Ruby Gupta William Beaumont Hospital, Department of Hematology and Medical Oncology, Royal Oak, Michigan, USA
  • Sukhmani Singh William Beaumont Hospital, Department of Hematology and Medical Oncology, Royal Oak, Michigan, USA
  • Nwabundo Anusim William Beaumont Hospital, Department of Hematology and Medical Oncology, Royal Oak, Michigan, USA
  • Sachin Gupta Reading Hospital, Department of Internal Medicine, Reading, Pennsylvania, USA
  • Sorab Gupta Bronx Care Hospital, Department of Hematology and Medical Oncology, Bronx, NY, USA
  • Marianne Huben William Beaumont Hospital, Department of Hematology and Medical Oncology, Royal Oak, Michigan, USA
  • George Howard William Beaumont Hospital, Department of Hematology and Medical Oncology, Royal Oak, Michigan, USA
  • Ishmael Jaiyesimi William Beaumont Hospital, Department of Hematology and Medical Oncology, Royal Oak, Michigan, USA

Keywords

Coronavirus disease 2019, cold agglutinin syndrome, case report, autoimmune hemolytic anemia

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality worldwide. While patients with COVID-19 most frequently present with pneumonia, respiratory failure and acute respiratory distress syndrome, increasing cases of immune-mediated disorders such as autoimmune thrombocytopenia, haemolytic anaemia and antiphospholipid syndrome have been reported. In this article we describe a rare case of cold agglutinin syndrome (CAS) in a patient with COVID-19. The patient was a 77-year-old man with a history of glucose-6-phosphate dehydrogenase (G6PD) deficiency who presented with COVID-19 infection and acute respiratory failure. Initially he was started on intravenous steroids, antibiotics and hydroxychloroquine. Laboratory analysis revealed haemolytic anaemia with a positive direct anti-globulin test (DAT) and high titres of cold agglutinins. Hydroxychloroquine was stopped due to suspicion of haemolysis due to G6PD deficiency but the haemolysis persisted. Unfortunately, the respiratory failure progressed and the patient died. In summary, this article describes a rare case of CAS associated with COVID-19. CAS is a heterogenous group of cold autoimmune haemolytic anaemias occurring secondary to infections or malignancies. No definite treatment for CAS in COVID-19 patients has been approved so far.

VIEW THE ENTIRE ARTICLE

References

  • Pal M, Berhanu G, Desalegn C,et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus 2020;12(3):e7423.
  • Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–1034.
  • Haigh K, Syrimi ZJ, Irvine S,et al. Hyperinflammation with COVID-19: thekey to patient deterioration? Clin Infect Pract 2020;7–8:100033.
  • Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382:e38.
  • Zulfiqar A-A, Lorenzo-Villalba N, Hassler P,et al.Immune thrombocytopenic purpura in a patient with Covid-19. N Engl J Med 2020;382:e43.
  • Lazarian G, Quinquenel A, BellalM, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol 2020;190(1):29–31.
  • Zagorski E, Pawar T, Rahimian S,et al. Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19). Br J Haematol 2020;190(4):e183–e184.
  • Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K. Severe autoimmune hemolytic anemiain COVID-19 infection, safely treated with steroids.Mediterr J Hematol Infect Dis 2020;12(1):e2020053.
  • Jacobs J, Eichbaum Q. COVID-19 associated with severe autoimmune hemolytic anemia. Transfusion 2020;61(2):635–640.
  • Jawed M, Hart E, Saeed M. Haemolytic anaemia: a consequence of COVID-19. BMJ Case Rep 2020;13(12):e238118.
  • Campos-Cabrera G, Mendez-Garcia E, Mora-Torres M, et al. Autoimmune hemolytic anemia as initial presentation of COVID-19 infection. Blood 2020;136(Suppl 1):8.
  • Capes A, Bailly S, Hantson P, Gerard L, Laterre PF. COVID-19 infection associated with autoimmune hemolytic anemia. Ann Hematol 2020;Z99(7):1679–1680.
  • Berentsen, S, Ulvestad, E, Langholm, R, et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 2006;91(4):460-466.
  • Berentsen, S. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia. Front Immunol 2020;11:590.
  • Li M, Nguyen C, Yeung Z,et al. Evans syndrome in a patient with Covid-19. Br J Haematol 2020;190(2):e59–e61.
  • Published: 2021-03-10

    Issue: Vol 8 No 3 (view)

    Section: Articles

    How to cite:
    1.
    Gupta R, Singh S, Anusim N, Gupta S, Gupta S, Huben M, Howard G, Jaiyesimi I. Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case. EJCRIM 2021;8 doi:10.12890/2021_002387.